Virbamec Vet 10 mg/ml injektioneste, liuos Finlandia - finés - Fimea (Suomen lääkevirasto)

virbamec vet 10 mg/ml injektioneste, liuos

virbac - ivermectin - injektioneste, liuos - 10 mg/ml - ivermektiini

Noromectin Pour-on vet 5 mg/ml kertavaleluliuos Finlandia - finés - Fimea (Suomen lääkevirasto)

noromectin pour-on vet 5 mg/ml kertavaleluliuos

norbrook laboratories (ireland) limited - ivermectin - kertavaleluliuos - 5 mg/ml - ivermektiini

Bimectin Vet 10 mg/ml injektioneste, liuos Finlandia - finés - Fimea (Suomen lääkevirasto)

bimectin vet 10 mg/ml injektioneste, liuos

bimeda animal health limited - ivermectin - injektioneste, liuos - 10 mg/ml - ivermektiini

Animec vet 10 mg/ml injektioneste, liuos Finlandia - finés - Fimea (Suomen lääkevirasto)

animec vet 10 mg/ml injektioneste, liuos

chanelle pharmaceuticals manufacturing limited - ivermectin - injektioneste, liuos - 10 mg/ml - ivermektiini

Butox vet 7.5 mg/ml kertavalelususpensio Finlandia - finés - Fimea (Suomen lääkevirasto)

butox vet 7.5 mg/ml kertavalelususpensio

intervet international b.v. - deltamethrin - kertavalelususpensio - 7.5 mg/ml - deltametriini

Neoprinil Pour-on 5 mg/ml kertavaleluliuos Finlandia - finés - Fimea (Suomen lääkevirasto)

neoprinil pour-on 5 mg/ml kertavaleluliuos

virbac - eprinomectin - kertavaleluliuos - 5 mg/ml - eprinomektiini

Dectospot vet 10 mg/ml kertavaleluliuos Finlandia - finés - Fimea (Suomen lääkevirasto)

dectospot vet 10 mg/ml kertavaleluliuos

bimeda animal health limited - deltamethrin - kertavaleluliuos - 10 mg/ml - deltametriini

Eprinex vet. 5 mg/ml kertavaleluliuos Finlandia - finés - Fimea (Suomen lääkevirasto)

eprinex vet. 5 mg/ml kertavaleluliuos

boehringer ingelheim animal health nordics a/s - eprinomectin - kertavaleluliuos - 5 mg/ml - eprinomektiini

Longrange Unión Europea - finés - EMA (European Medicines Agency)

longrange

merial - eprinomectin - endektosidit - karja - hoitoa seuraavien loisten:ruoansulatuskanavan sukkulamadot (täysikasvuiset ja l4):- ostertagia ostertagi/lyrata, cooperia oncophora/surnabada, c. punctata, haemonchus contortus, trichostrongylus axel, t. colubriformis, bunostomum phlebotomum, nematodirus helvetianus, oesophagostomum radiatumlungworm (aikuiset ja l4):- dictyocaulus viviparuswarbles (lois-vaiheet):- hypoderma bovis, s. lineatummange punkit:- sarcoptes scabiei var. bovis täitä: linognathus vituli, haematopinus eurysternus, solenoptes capillatushorn lentää: haematobia irritansprevention ja reinfections seuraavat parasiitit:- dictyocaulus viviparus, ostertagia ostertagi/lyrata, trichostrongylus colubriformis, haemonchus contortus, ja bunostomum phlebotomum;- oesophagostomum radiatum, cooperia oncophora/surnabada, c. punctata ja trichostrongylus axel.

Vidaza Unión Europea - finés - EMA (European Medicines Agency)

vidaza

bristol-myers squibb pharma eeig - atsakitidiini - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - antineoplastiset aineet - vidaza is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with: intermediate 2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29 % marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30 % blasts and multi-lineage dysplasia, according to world health organisation (who) classification. vidaza is indicated for the treatment of adult patients aged 65 years or older who are not eligible for hsct with aml with >30% marrow blasts according to the who classification.